NCT02680743View on ClinicalTrials.gov

Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 28, 2016

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Congenital CMV Infection
Interventions
OTHER

Education of parents to pursue prompt hearing screening.

Parents of patients will be counseled on the risks of hearing loss with a positive screen.

Trial Locations (2)

68123

Nebraska Medicine Bellevue, Bellevue

68198

Unversity of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT02680743 - Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit | Biotech Hunter | Biotech Hunter